0001908215-22-000001.txt : 20220202 0001908215-22-000001.hdr.sgml : 20220202 20220202112926 ACCESSION NUMBER: 0001908215-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 EFFECTIVENESS DATE: 20220202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Design Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001908215 IRS NUMBER: 851208626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-431865 FILM NUMBER: 22582122 BUSINESS ADDRESS: STREET 1: 237 PUTNAM AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-553-1402 MAIL ADDRESS: STREET 1: 237 PUTNAM AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001908215 Design Pharmaceuticals, Inc. 237 PUTNAM AVENUE CAMBRIDGE MA MASSACHUSETTS 02139 617-553-1402 DELAWARE None None Corporation true 2018 Dirk Loeffert 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Rob Nicol 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Olivier Clyti 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Director Fred Dom 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Director John Hastewell 237 Putnam Avenue Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2022-01-12 false true false 0 3000000 3000000 0 false 1 0 0 0 false Design Pharmaceuticals, Inc. /s/ Dirk Loeffert Dirk Loeffert Chief Executive Officer 2022-02-02